|Bid||8.05 x 900|
|Ask||8.43 x 1100|
|Day's Range||7.67 - 8.17|
|52 Week Range||7.56 - 16.68|
|Beta (5Y Monthly)||0.02|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 01, 2022 - Aug 05, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||22.75|
Subscribe to Yahoo Finance Plus to view Fair Value for KNSA
Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA ) came out with its first-quarter results last week, and we wanted to see...
Kiniksa Pharmaceuticals, Ltd. (KNSA) delivered earnings and revenue surprises of 30.77% and 0.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
HAMILTON, Bermuda, May 02, 2022 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, May 3, 2022, at 8:30 a.m. Eastern Time to report its first quarter 2022 financial results and corporate activities. A live webcast will be accessible through the Investors & Media section of the company’s website at www.kiniksa.com. A replay of the webcast will also be available on Kiniksa’s website within approximately